253 related articles for article (PubMed ID: 24745769)
1. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
[TBL] [Abstract][Full Text] [Related]
2. Interobserver Reproducibility of Histological Grading of Canine Simple Mammary Carcinomas.
Santos M; Correia-Gomes C; Santos A; de Matos A; Dias-Pereira P; Lopes C
J Comp Pathol; 2015 Jul; 153(1):22-7. PubMed ID: 25979682
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
[TBL] [Abstract][Full Text] [Related]
4. Value of the Nottingham Histological Grading Parameters and Nottingham Prognostic Index in Canine Mammary Carcinoma.
Santos M; Correia-Gomes C; Marcos R; Santos A; De Matos A; Lopes C; Dias-Pereira P
Anticancer Res; 2015 Jul; 35(7):4219-27. PubMed ID: 26124382
[TBL] [Abstract][Full Text] [Related]
5. Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time.
Diessler ME; Castellano MC; Portiansky EL; Burns S; Idiart JR
Vet Comp Oncol; 2017 Jun; 15(2):450-461. PubMed ID: 26833549
[TBL] [Abstract][Full Text] [Related]
6. Developing and testing prognostic bio-scoring systems for canine mammary gland carcinomas.
Sorenmo KU; Durham AC; Kristiansen V; Pena L; Goldschmidt MH; Stefanovski D
Vet Comp Oncol; 2019 Dec; 17(4):479-488. PubMed ID: 31099972
[TBL] [Abstract][Full Text] [Related]
7. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method.
Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A
J Comp Pathol; 2005 Nov; 133(4):246-52. PubMed ID: 16202421
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of those histopathologic parameters predictive of invasion of the lymphatic system by canine mammary carcinomas.
Rasotto R; Zappulli V; Castagnaro M; Goldschmidt MH
Vet Pathol; 2012 Mar; 49(2):330-40. PubMed ID: 21670194
[TBL] [Abstract][Full Text] [Related]
9. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
10. Use of the optical disector in canine mammary simple and complex carcinomas.
Santos M; Dias-Pereira P; Correia-Gomes C; Marcos R; de Matos A; Rocha E; Lopes C
APMIS; 2017 Sep; 125(9):833-839. PubMed ID: 28586148
[TBL] [Abstract][Full Text] [Related]
11. Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis.
Seixas F; Palmeira C; Pires MA; Bento MJ; Lopes C
Vet J; 2011 Jan; 187(1):65-71. PubMed ID: 19955006
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Histological Grade and Histopathological Appearance in Canine Mammary Carcinomas.
Tanaka Y; Koyama K; Horiuchi N; Watanabe K; Kobayashi Y
J Comp Pathol; 2020 Aug; 179():59-64. PubMed ID: 32958149
[TBL] [Abstract][Full Text] [Related]
13. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
Pereira PD; Lopes CC; Matos AJ; Cortez PP; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2010; 143(2-3):87-93. PubMed ID: 20153868
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of regional lymph node status in canine mammary carcinomas.
Szczubiał M; Łopuszynski W
Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a new histological and molecular-based classification of canine mammary neoplasia.
Im KS; Kim NH; Lim HY; Kim HW; Shin JI; Sur JH
Vet Pathol; 2014 May; 51(3):549-59. PubMed ID: 24003019
[TBL] [Abstract][Full Text] [Related]
17. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables.
Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F
J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours.
Santos A; Lopes C; Marques RM; Amorim I; Ribeiro J; Frias C; Vicente C; Gärtner F; de Matos A
Vet J; 2011 Jul; 189(1):43-8. PubMed ID: 20598596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
